SONEXA THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://sonexa.com
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)A Pilot Efficacy and Safety Study of ST101 in Essential Tremor
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2012-01-06
- Lead Sponsor
- Sonexa Therapeutics, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT01332695
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- Sonexa Therapeutics, Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT00842673
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- Sonexa Therapeutics, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT00842816
News
No news found